MDxHealth SA (MDXH) Stock Price
$3.29 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
9
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on MDxHealth SA, AI stock picks, stock alerts and much more.
MDXH AI Stock Analysis
AI stock analysis for MDXH is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MDxHealth SA (MDXH) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MDxHealth SA (MDXH) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MDxHealth SA (MDXH), currently trading at $3.29, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MDXH
-
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally.
-
Symbol
MDXH
-
Market
NASDAQ
-
Industry
Medical - Diagnostics & Research
-
Market Cap
162.8M
Similar Stocks
 |
Bionano Genomics BNGO |
$4 3.2% |
3 |
 |
Illumina ILMN |
$101.8 2.5% |
4 |
 |
Neogen NEOG |
$5.64 0.7% |
5 |
 |
DarioHealth DRIO |
$0.5701 3.7% |
3 |
 |
Idexx Laboratories IDXX |
$645.6 2% |
6 |
MDXH Alternative Data
Web Traffic
MDxHealth SA receives an estimated 10648 monthly visitors to mdxhealth.com.
-
Web Traffic
10648
-
Change from Previous Month
20.5%
-
3 Month Change
83.5%
-
YoY Change
83.5%
Twitter Followers
MDxHealth SA has 1,382 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.
-
Twitter Followers
1382
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Facebook Engagement
MDxHealth SA has engaged 1 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Followers
7,642 are following MDxHealth SA on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
7642
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
4%
Job Postings
MDxHealth SA has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
100%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Employees
According to LinkedIn, MDxHealth SA has 270 employees, down by -0.4% over the last month.
-
LinkedIn Employees
270
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Reddit Mentions
MDxHealth SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at MDxHealth SA is 29 out of 100 (bearish).
-
Business Outlook
29
-
Change from Previous Month
17.1%
-
3 Month Change
17.1%
-
YoY Change
17.1%
News Mentions
MDxHealth SA was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
MDXH Financials
MDXH Key Metrics
-
Total Revenue
$24.7M
-
Net Income
-$6.8M
-
Earnings per Share
-$0.14
-
Free cash flow
-$3.3M
-
EBITDA
-$2.4M
-
EBITDA Ratio
-0.0976191
-
Total Assets
$157.3M
MDXH 2-year Revenue & Income
MDXH 2-year Free Cash Flow
MDXH Technicals
MDXH SMA
MDXH RSI
FAQ
What's the current price of MDxHealth SA (MDXH) Stock?
The price of an MDxHealth SA (MDXH) share is $3.29.
What's the market cap of MDxHealth SA?
The current market cap of MDxHealth SA is 162.8M.
Should I buy or sell MDXH?
MDxHealth SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, MDxHealth SA is better viewed as a hold or accumulate position while waiting for further developments.
Is MDxHealth SA a good investment?
The current analysis of MDxHealth SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in MDxHealth SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy MDxHealth SA (MDXH) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for MDxHealth SA stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to MDxHealth SA (MDXH) that investors often compare it to?
MDxHealth SA (MDXH) is often compared to similar stocks such as Bionano Genomics, Illumina, Neogen, DarioHealth and Idexx Laboratories.
What is the forecast for MDxHealth SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MDxHealth SA's stock price to be around $3.2 in 2026. Starting from the current price of $3.29, this represents a 2.7% change in price, indicating a neutral outlook for the stock.
How to buy MDxHealth SA (MDXH) Stock?
MDxHealth SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MDxHealth SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.